Correlation Between GlaxoSmithKline PLC and Mfs Mid

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Mfs Mid at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Mfs Mid into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Mfs Mid Cap, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Mfs Mid and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Mfs Mid. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Mfs Mid.

Diversification Opportunities for GlaxoSmithKline PLC and Mfs Mid

-0.84
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GlaxoSmithKline and Mfs is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Mfs Mid Cap in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mfs Mid Cap and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Mfs Mid. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mfs Mid Cap has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Mfs Mid go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Mfs Mid

Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 13.07 times less return on investment than Mfs Mid. In addition to that, GlaxoSmithKline PLC is 1.64 times more volatile than Mfs Mid Cap. It trades about 0.01 of its total potential returns per unit of risk. Mfs Mid Cap is currently generating about 0.16 per unit of volatility. If you would invest  2,638  in Mfs Mid Cap on August 25, 2024 and sell it today you would earn a total of  1,113  from holding Mfs Mid Cap or generate 42.19% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy99.63%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Mfs Mid Cap

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Mfs Mid Cap 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Mfs Mid Cap are ranked lower than 10 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak forward-looking signals, Mfs Mid may actually be approaching a critical reversion point that can send shares even higher in December 2024.

GlaxoSmithKline PLC and Mfs Mid Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Mfs Mid

The main advantage of trading using opposite GlaxoSmithKline PLC and Mfs Mid positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Mfs Mid can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mfs Mid will offset losses from the drop in Mfs Mid's long position.
The idea behind GlaxoSmithKline PLC ADR and Mfs Mid Cap pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings